##gff-version 3 Q9X2V7 UniProtKB Propeptide 1 37 . . . ID=PRO_0000002774;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10092860;Dbxref=PMID:10092860 Q9X2V7 UniProtKB Peptide 38 58 . . . ID=PRO_0000002775;Note=Microcin J25;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10092860;Dbxref=PMID:10092860 Q9X2V7 UniProtKB Site 41 41 . . . Note=Essential for permeation into bacteria;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18632663;Dbxref=PMID:18632663 Q9X2V7 UniProtKB Site 44 44 . . . Note=Essential for permeation into bacteria;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18632663;Dbxref=PMID:18632663 Q9X2V7 UniProtKB Site 46 46 . . . Note=Essential for permeation into bacteria and for RNAP inhibition;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18632663;Dbxref=PMID:18632663 Q9X2V7 UniProtKB Site 47 47 . . . Note=Essential for permeation into bacteria;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18632663;Dbxref=PMID:18632663 Q9X2V7 UniProtKB Site 56 56 . . . Note=Essential for permeation into bacteria;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18632663;Dbxref=PMID:18632663 Q9X2V7 UniProtKB Site 57 57 . . . Note=Essential for permeation into bacteria;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18632663;Dbxref=PMID:18632663 Q9X2V7 UniProtKB Cross-link 38 45 . . . Note=Isoglutamyl glycine isopeptide (Gly-Glu);Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14531661,ECO:0000269|PubMed:14531690,ECO:0000269|PubMed:14531691;Dbxref=PMID:14531661,PMID:14531690,PMID:14531691 Q9X2V7 UniProtKB Mutagenesis 41 41 . . . Note=Loss of RNAP inhibition and loss of bacterial growth inhibition. G->A%2CC%2CD%2CE%2CF%2CG%2CH%2CI%2CK%2CL%2CM%2CN%2CP%2CQ%2CR%2CT%2CV%2CW%2CY;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18632663;Dbxref=PMID:18632663 Q9X2V7 UniProtKB Mutagenesis 41 41 . . . Note=No change of RNAP inhibition but loss of bacterial growth inhibition. G->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18632663;Dbxref=PMID:18632663 Q9X2V7 UniProtKB Mutagenesis 44 44 . . . Note=No change of RNAP inhibition but loss of bacterial growth inhibition. P->A%2CL%2CV;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18632663;Dbxref=PMID:18632663 Q9X2V7 UniProtKB Mutagenesis 44 44 . . . Note=Loss of RNAP inhibition and loss of bacterial growth inhibition. P->C%2CD%2CE%2CF%2CG%2CH%2CI%2CK%2CM%2CN%2CP%2CQ%2CR%2CS%2CT%2CW%2CY;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18632663;Dbxref=PMID:18632663 Q9X2V7 UniProtKB Mutagenesis 46 46 . . . Note=Loss of RNAP inhibition. Y->A%2CC%2CD%2CE%2CF%2CG%2CH%2CI%2CK%2CL%2CM%2CN%2CP%2CQ%2CR%2CS%2CT%2CV%2CW%2CY;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18632663;Dbxref=PMID:18632663 Q9X2V7 UniProtKB Mutagenesis 47 47 . . . Note=Loss of RNAP inhibition and loss of bacterial growth inhibition. F->A%2CC%2CD%2CE%2CF%2CG%2CH%2CK%2CL%2CN%2CP%2CQ%2CT%2CV%2CY;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18632663;Dbxref=PMID:18632663 Q9X2V7 UniProtKB Mutagenesis 47 47 . . . Note=No change of RNAP inhibition but loss of bacterial growth inhibition. F->I%2CM%2CR%2CS%2CW;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18632663;Dbxref=PMID:18632663 Q9X2V7 UniProtKB Mutagenesis 50 50 . . . Note=Increase in bacterial growth inhibition. I->A%2CL%2CM%2CN%2CP%2CR%2CT;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18632663;Dbxref=PMID:18632663 Q9X2V7 UniProtKB Mutagenesis 52 52 . . . Note=Increase in bacterial growth inhibition. T->A%2CF%2CH%2CL;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18632663;Dbxref=PMID:18632663 Q9X2V7 UniProtKB Mutagenesis 52 52 . . . Note=No change of RNAP inhibition but increase in permeation into bacterial cells and bacterial growth inhibition. T->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18632663;Dbxref=PMID:18632663 Q9X2V7 UniProtKB Mutagenesis 56 56 . . . Note=Loss of RNAP inhibition and loss of bacterial growth inhibition. F->A%2CC%2CD%2CE%2CF%2CG%2CH%2CI%2CK%2CL%2CM%2CN%2CP%2CQ%2CR%2CS%2CT%2CV;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18632663;Dbxref=PMID:18632663 Q9X2V7 UniProtKB Mutagenesis 56 56 . . . Note=No change of RNAP inhibition but loss of bacterial growth inhibition. F->W%2CY;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18632663;Dbxref=PMID:18632663 Q9X2V7 UniProtKB Mutagenesis 57 57 . . . Note=Loss RNAP inhibition%2C and loss of bacterial growth inhibition. Y->A%2CC%2CD%2CE%2CF%2CG%2CH%2CI%2CK%2CL%2CM%2CN%2CP%2CQ%2CR%2CS%2CT%2CV%2CW%2CY;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18632663;Dbxref=PMID:18632663 Q9X2V7 UniProtKB Mutagenesis 57 57 . . . Note=No change of RNAP inhibition%2C and loss of bacterial growth inhibition. Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18632663;Dbxref=PMID:18632663 Q9X2V7 UniProtKB Beta strand 39 44 . . . Ontology_term=ECO:0007829;evidence=ECO:0007829|PDB:4CU4 Q9X2V7 UniProtKB Beta strand 48 51 . . . Ontology_term=ECO:0007829;evidence=ECO:0007829|PDB:1PP5 Q9X2V7 UniProtKB Beta strand 55 57 . . . Ontology_term=ECO:0007829;evidence=ECO:0007829|PDB:1PP5